Article
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.
British journal of clinical pharmacology - 1 Jan 2023
Lehtisalo Minna, Taskinen Suvi, Tarkiainen E Katriina, Neuvonen Mikko, Viinamäki Jenni, Paile-Hyvärinen Maria, Lilius Tuomas O, Tapaninen Tuija, Backman Janne T, Tornio Aleksi, Niemi Mikko
Abstract excerpt
AIMS: The aim was to comprehensively investigate the effects of genetic variability on the pharmacokinetics of rosuvastatin. METHODS: We conducted a genome-wide association study and candidate gene analyses of single dose rosuvastatin pharmacokinetics in a prospective study (n = 159) and a cohort of previously published studies (n = 88). RESULTS: In a genome-wide association meta-analysis of the prospective study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
